Correlation between RPPA expression and clinical features

Skin Cutaneous Melanoma (Metastatic)

23 May 2013 | analyses__2013_05_23

Maintainer Information

Citation Information

Maintained by Juok Cho (Broad Institute)

Cite as Broad Institute TCGA Genome Data Analysis Center (2013): Correlation between RPPA expression and clinical features. Broad Institute of MIT and Harvard. doi:10.7908/C15Q4T5J

Overview

Introduction

This pipeline uses various statistical tests to identify RPPAs whose expression levels correlated to selected clinical features.

Summary

Testing the association between 175 genes and 7 clinical features across 109 samples, statistically thresholded by Q value < 0.05, 3 clinical features related to at least one genes.

1 gene correlated to 'Time to Death'.

GSK3A GSK3B|GSK3-ALPHA-BETA-M-V

1 gene correlated to 'DISTANT.METASTASIS'.

C12ORF5|TIGAR-R-V

2 genes correlated to 'LYMPH.NODE.METASTASIS'.

PGR|PR-R-V , ESR1|ER-ALPHA-R-V

No genes correlated to 'AGE', 'PRIMARY.SITE.OF.DISEASE', 'GENDER', and 'NEOPLASM.DISEASESTAGE'.

Results

Overview of the results

Complete statistical result table is provided in Supplement Table 1

Table 1. Get Full Table This table shows the clinical features, statistical methods used, and the number of genes that are significantly associated with each clinical feature at Q value < 0.05.

Clinical feature	Statistical test	Significant genes	Associated with		Associated with
Time to Death	Cox regression test	N=1	shorter survival	N=1	longer survival	N=0
AGE	Spearman correlation test	N=0
PRIMARY SITE OF DISEASE	ANOVA test	N=0
GENDER	t test	N=0
DISTANT METASTASIS	ANOVA test	N=1
LYMPH NODE METASTASIS	ANOVA test	N=2
NEOPLASM DISEASESTAGE	ANOVA test	N=0

Clinical variable #1: 'Time to Death'

One gene related to 'Time to Death'.

Table S1. Basic characteristics of clinical feature: 'Time to Death'


Time to Death	Duration (Months)	2.6-357.4 (median=47.5)
	censored	N = 50
	death	N = 58

	Significant markers	N = 1
	associated with shorter survival	1
	associated with longer survival	0

List of one gene significantly associated with 'Time to Death' by Cox regression test

Table S2. Get Full Table List of one gene significantly associated with 'Time to Death' by Cox regression test

	HazardRatio	Wald_P	Q	C_index
GSK3A GSK3B\|GSK3-ALPHA-BETA-M-V	9.1	0.0002674	0.047	0.624

Figure S1. Get High-res Image As an example, this figure shows the association of GSK3A GSK3B|GSK3-ALPHA-BETA-M-V to 'Time to Death'. four curves present the cumulative survival rates of 4 quartile subsets of patients. P value = 0.000267 with univariate Cox regression analysis using continuous log-2 expression values.

Clinical variable #2: 'AGE'

No gene related to 'AGE'.

Table S3. Basic characteristics of clinical feature: 'AGE'


AGE	Mean (SD)	56.4 (17)
	Significant markers	N = 0

Clinical variable #3: 'PRIMARY.SITE.OF.DISEASE'

No gene related to 'PRIMARY.SITE.OF.DISEASE'.

Table S4. Basic characteristics of clinical feature: 'PRIMARY.SITE.OF.DISEASE'


PRIMARY.SITE.OF.DISEASE	Labels	N
	DISTANT METASTASIS	13
	PRIMARY TUMOR	1
	REGIONAL CUTANEOUS OR SUBCUTANEOUS TISSUE (INCLUDES SATELLITE AND IN-TRANSIT METASTASIS)	15
	REGIONAL LYMPH NODE	80

	Significant markers	N = 0

Clinical variable #4: 'GENDER'

No gene related to 'GENDER'.

Table S5. Basic characteristics of clinical feature: 'GENDER'


GENDER	Labels	N
	FEMALE	44
	MALE	65

	Significant markers	N = 0

Clinical variable #5: 'DISTANT.METASTASIS'

One gene related to 'DISTANT.METASTASIS'.

Table S6. Basic characteristics of clinical feature: 'DISTANT.METASTASIS'


DISTANT.METASTASIS	Labels	N
	M0	90
	M1	1
	M1B	2
	M1C	2

	Significant markers	N = 1

List of one gene differentially expressed by 'DISTANT.METASTASIS'

Table S7. Get Full Table List of one gene differentially expressed by 'DISTANT.METASTASIS'

	ANOVA_P	Q
C12ORF5\|TIGAR-R-V	0.0001783	0.0312

Figure S2. Get High-res Image As an example, this figure shows the association of C12ORF5|TIGAR-R-V to 'DISTANT.METASTASIS'. P value = 0.000178 with ANOVA analysis.

Clinical variable #6: 'LYMPH.NODE.METASTASIS'

2 genes related to 'LYMPH.NODE.METASTASIS'.

Table S8. Basic characteristics of clinical feature: 'LYMPH.NODE.METASTASIS'


LYMPH.NODE.METASTASIS	Labels	N
	N0	56
	N1	2
	N1A	3
	N1B	13
	N2A	2
	N2B	5
	N2C	4
	N3	9
	NX	2

	Significant markers	N = 2

List of 2 genes differentially expressed by 'LYMPH.NODE.METASTASIS'

Table S9. Get Full Table List of 2 genes differentially expressed by 'LYMPH.NODE.METASTASIS'

	ANOVA_P	Q
PGR\|PR-R-V	3.618e-08	6.33e-06
ESR1\|ER-ALPHA-R-V	8.673e-08	1.51e-05

Figure S3. Get High-res Image As an example, this figure shows the association of PGR|PR-R-V to 'LYMPH.NODE.METASTASIS'. P value = 3.62e-08 with ANOVA analysis.

Clinical variable #7: 'NEOPLASM.DISEASESTAGE'

No gene related to 'NEOPLASM.DISEASESTAGE'.

Table S10. Basic characteristics of clinical feature: 'NEOPLASM.DISEASESTAGE'


NEOPLASM.DISEASESTAGE	Labels	N
	I OR II NOS	3
	STAGE I	11
	STAGE IA	8
	STAGE IB	8
	STAGE II	10
	STAGE IIA	5
	STAGE IIB	5
	STAGE IIC	3
	STAGE III	6
	STAGE IIIA	2
	STAGE IIIB	11
	STAGE IIIC	13
	STAGE IV	4

	Significant markers	N = 0

Methods & Data

Input

Expresson data file = SKCM-TM.rppa.txt
Clinical data file = SKCM-TM.clin.merged.picked.txt
Number of patients = 109
Number of genes = 175
Number of clinical features = 7

Survival analysis

For survival clinical features, Wald's test in univariate Cox regression analysis with proportional hazards model (Andersen and Gill 1982) was used to estimate the P values using the 'coxph' function in R. Kaplan-Meier survival curves were plot using the four quartile subgroups of patients based on expression levels

Correlation analysis

For continuous numerical clinical features, Spearman's rank correlation coefficients (Spearman 1904) and two-tailed P values were estimated using 'cor.test' function in R

ANOVA analysis

For multi-class clinical features (ordinal or nominal), one-way analysis of variance (Howell 2002) was applied to compare the log2-expression levels between different clinical classes using 'anova' function in R

Student's t-test analysis

For two-class clinical features, two-tailed Student's t test with unequal variance (Lehmann and Romano 2005) was applied to compare the log2-expression levels between the two clinical classes using 't.test' function in R

Q value calculation

For multiple hypothesis correction, Q value is the False Discovery Rate (FDR) analogue of the P value (Benjamini and Hochberg 1995), defined as the minimum FDR at which the test may be called significant. We used the 'Benjamini and Hochberg' method of 'p.adjust' function in R to convert P values into Q values.

Download Results

This is an experimental feature. The full results of the analysis summarized in this report can be downloaded from the TCGA Data Coordination Center.

References

[1] Andersen and Gill, Cox's regression model for counting processes, a large sample study, Annals of Statistics 10(4):1100-1120 (1982)

[2] Spearman, C, The proof and measurement of association between two things, Amer. J. Psychol 15:72-101 (1904)

[3] Howell, D, Statistical Methods for Psychology. (5th ed.), Duxbury Press:324-5 (2002)

[4] Lehmann and Romano, Testing Statistical Hypotheses (3E ed.), New York: Springer. ISBN 0387988645 (2005)

[5] Benjamini and Hochberg, Controlling the false discovery rate: a practical and powerful approach to multiple testing, Journal of the Royal Statistical Society Series B 59:289-300 (1995)

Made with Nozzle